Westminster, CO, United States of America

Alyssa Carlson


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Gene Editing: The Work of Alyssa Carlson

Introduction

Alyssa Carlson, an emerging inventor based in Westminster, CO, is making significant contributions to the field of gene editing. With two patents to her name, she is at the forefront of utilizing CRISPR technology for innovative genetic modifications. Her work represents a blend of creativity and scientific rigor, shaping the future of genetic research and therapy.

Latest Patents

Alyssa's most recent patents revolve around compositions and methods aimed at targeting, editing, or modifying genes. These patents include nucleic acids that serve as guide nucleic acids (gNAs), particularly guide ribonucleic acids (gRNAs) within the CRISPR system. The innovations described herein involve modifications to nucleotides that enhance the function of these guide nucleic acids, facilitating their use in modifying cells and other crucial applications involving CRISPR Cas proteins.

Career Highlights

Alyssa Carlson is currently affiliated with Celyntra Therapeutics SA, where her cutting-edge research focuses on leveraging CRISPR technology to address complex genetic challenges. Her academic background and extensive research experience have established her as a knowledgeable figure in genetic modifications. The implications of her work extend beyond academic pursuits, promising advancements in medicine and biotechnology.

Collaborations

In her endeavors, Alyssa collaborates with notable colleagues such as Andrea Barghetti and Roland Baumgartner. Together, they strive to push the boundaries of what's possible in genetic engineering, sharing insights and expertise that enhance their collective research efforts.

Conclusion

Alyssa Carlson is a visionary inventor whose patents signify important advancements in gene editing technologies. Her contributions at Celyntra Therapeutics SA, alongside her talented coworkers, underscore the potential of collaborative research in driving innovation. As the field of genetics continues to evolve, Alyssa's inventions will undoubtedly play a pivotal role in shaping future therapies and applications in biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…